Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fontana, R. J.
* Articles by Moyer, C. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Fontana, R. J.
* Articles by Moyer, C. A.
Related Collections
* Syndromes Secondary to General Medical Disorders
Psychosomatics 43:378-385, October 2002
© 2002 The Academy of Psychosomatic Medicine

Emotional Distress During Interferon-{alpha}-2B and Ribavirin Treatment of Chronic Hepatitis C

Robert J. Fontana, M.D., Steven M. Schwartz, Ph.D., Achamyeleh Gebremariam, M.S., Anna S.F. Lok, M.D., and Cheryl A. Moyer, M.S.

Received July 2, 2001; revision received Jan. 24, 2002; accepted Feb. 13, 2002. From the Departments of Internal Medicine and Psychiatry and the Consortium for Health Outcomes Innovation and Cost-Effectiveness Studies, University of Michigan Medical School, Ann Arbor. Address reprint requests to Dr. Fontana, 3912 Taubman Center, Ann Arbor, MI 48109-0362; rfontana{at}umich.edu (e-mail).

The aim of the study was to describe the use of the Brief Symptom Inventory in characterizing the type and severity of emotional distress in 26 patients with chronic hepatitis C who were receiving interferon-{alpha}-2B and ribavirin. The 6-month actuarial incidence of neuropsychiatric toxicity, determined by physician interview, was 58%. Significant differences in mean depression, anxiety, and somatization Brief Symptom Inventory T scores were noted in the 15 patients with clinically apparent neuropsychiatric toxicity compared to the 11 patients without neuropsychiatric toxicity. Because of its brevity and simplicity, the Brief Symptom Inventory may prove to be a useful adjunct to clinician assessment in detecting and monitoring emotional distress during interferon-{alpha} treatment of chronic hepatitis C.







Get information about faster international access.

Privacy Policy

Copyright © 2002 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org